Manufacturer record

GNB Medica Labs: regulatory record

Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories

3 batches manufactured by GNB Medica Labs (Himachal Pradesh) were declared Not of Standard Quality in October 2019. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.

Most recent flagged batch: TF19-88, Cefixime Dispersible Tablets (SAMCEF- 200DT TABLETS) (exp May 2021). RDTL Chandigarh (CDSCO lab) found it not of standard quality: Uniformity of dispersion and Disintegration. Listed in the October 2019 alert.

Records by type

3 records linked to GNB Medica Labs in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.

0Banned or prohibited
0Recalled or suspended
3Failed a lab test
0Regulatory notice
Primary government sourceTier 1: government primary source

CDSCO drug alerts: Not of Standard Quality and spurious drugs

CDSCO · CDSCO monthly NSQ alerts, Oct 2019 to Oct 2019

View original document

Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.

3
NSQ batches since 2019
3
Products affected
Assay
Most common failure
Oct 2019
Latest alert

Flagged batches per year

2019 · 3

All flagged batches

Product Batch Reason declared NSQ Tested by Alert
Cefixime Dispersible Tablets (SAMCEF- 200DT TABLETS) Batch TF19-88Mfg Jun 2019 · Exp May 2021 Uniformity of dispersion and DisintegrationDisintegration RDTL ChandigarhCDSCO lab Oct 2019
Amoxycillin and Potassium Clavulanate with Lactic Acid Bacillus Tablets (ANUMOX- CV-LB TABLETS) Batch TG19-36Mfg Jul 2019 · Exp Dec 2020 AssayAssay RDTL ChandigarhCDSCO lab Oct 2019
Amoxycillin and Potassium Clavulanate Tablets IP (ICLAVE-625 TABLETS) Batch TG19-32Mfg Jul 2019 · Exp Dec 2020 Dissolution and AssayAssay RDTL ChandigarhCDSCO lab Oct 2019

Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.